Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.42% inched 0.70% higher to $171.79 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.02% rising 2.43% to 4,431.85 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.34% rising 1.65% to 34,725.47. This was the stock's fourth consecutive day of gains. Johnson & Johnson closed $8.13 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +2.26% rose 0.99% to $383.25, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.74% rose 0.40% to $80.90, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.32% rose 1.80% to $54.33. Trading volume (9.7 M) eclipsed its 50-day average volume of 7.8 M.